EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.404
https://www.valueinhealthjournal.com/article/S1098-3015(24)00519-9/fulltext
Title :
EE105 Cost-Effectiveness Analysis of Linperlisib for Relapsed or Refractory Follicular Lymphoma Based on Matching Adjusted Indirect Comparison in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00519-9&doi=10.1016/j.jval.2024.03.404
First page :
Section Title :
Open access? :
No
Section Order :
11753